4D Molecular Therapeutics, Inc. (FDMT)
$14.67-$0.24 (-1.61%) Today
Scott Bizily - OfficerScott Bizily - Officer4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
https://www.4dmoleculartherapeutics.comSEC filings for FDMT on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 13 | 302,980 | $3.69M |
| Grant or award | 7 | 375,000 | |
| Option exercise | 12 | 139,292 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
33 Form 4 filings on record, the earliest from Nov 13, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Kirn - Officer | Option exercise | Common Stock | 50,000 | $4.14 | $207K | |
| David Kirn - Officer | Open-market sale | Common Stock | 43,149 | $15.36 | $663K | |
| David Kirn - Officer | Open-market sale | Common Stock | 25,927 | $16.42 | $426K | |
| David Kirn - Officer | Option exercise | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Scott Bizily - Officer | Option exercise | Common Stock | 1,635 | $4.14 | $7K | |
| Scott Bizily - Officer | Open-market sale | Common Stock | 1,635 | $12.00 | $20K | |
| Scott Bizily - Officer | Option exercise | Common Stock | 1,635 | $4.14 | $7K | |
| Scott Bizily - Officer | Open-market sale | Common Stock | 1,635 | $12.20 | $20K | |
| Scott Bizily - Officer | Option exercise | Stock Option (Right to Buy) | 1,635 | $0.00 | - | |
| Scott Bizily - Officer | Option exercise | Stock Option (Right to Buy) | 1,635 | $0.00 | - | |
| David Kirn - Officer | Open-market sale | Common Stock | 26,842 | $10.23 | $275K | |
| David Kirn - Officer | Open-market sale | Common Stock | 12,415 | $10.05 | $125K | |
| David Kirn - Officer | Open-market sale | Common Stock | 42,608 | $12.87 | $548K | |
| David Kirn - Officer | Open-market sale | Common Stock | 15,283 | $12.01 | $184K | |
| David Kirn - Officer | Open-market sale | Common Stock | 442 | $12.84 | $6K | |
| Scott Bizily - Officer | Option exercise | Common Stock | 814 | $4.14 | $3K | |
| Scott Bizily - Officer | Option exercise | Common Stock | 5,752 | $6.49 | $37K | |
| Scott Bizily - Officer | Open-market sale | Common Stock | 6,566 | $14.00 | $92K | |
| Scott Bizily - Officer | Option exercise | Stock Option (Right to Buy) | 814 | $0.00 | - | |
| Scott Bizily - Officer | Option exercise | Stock Option (Right to Buy) | 5,752 | $0.00 | - | |
| Scott Bizily - Officer | Option exercise | Common Stock | 9,810 | $4.14 | $41K | |
| Scott Bizily - Officer | Open-market sale | Common Stock | 9,810 | $12.00 | $118K | |
| Scott Bizily - Officer | Option exercise | Stock Option (Right to Buy) | 9,810 | $0.00 | - | |
| David Kirn - Officer | Open-market sale | Common Stock | 114,746 | $10.47 | $1.20M | |
| Shawn Tomasello | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Charles Theuer | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Nancy Miller-Rich | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
 Susannah Gray | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| John F. Milligan | Grant or award | Stock Option (Right to Buy) | 75,000 | $0.00 | - | |
| Glenn Sblendorio | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Jacob Chacko | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| David Kirn - Officer | Open-market sale | Common Stock | 1,922 | $10.02 | $19K | |
| David Kirn - Officer | Grant or award | Stock Option (Right to Buy) | 750,000 | $0.00 | - | |
| Scott Bizily - Officer | Grant or award | Stock Option (Right to Buy) | 217,000 | $0.00 | - | |
 Christopher Paul Simms - Officer | Grant or award | Stock Option (Right to Buy) | 219,000 | $0.00 | - | |
| Ashoo Gupta - Officer | Option exercise | Common Stock | 865 | - | - | |
| Ashoo Gupta - Officer | Open-market sale | Common Stock | 310 | $8.61 | $3K | |
| Ashoo Gupta - Officer | Option exercise | Common Stock | 221 | - | - | |
| Ashoo Gupta - Officer | Open-market sale | Common Stock | 80 | $8.61 | $689 | |
| Ashoo Gupta - Officer | Option exercise | Restricted Stock Units | 865 | $0.00 | - | |
| Ashoo Gupta - Officer | Option exercise | Restricted Stock Units | 221 | $0.00 | - | |
| Glenn Sblendorio | Grant or award | Stock Option (Right to Buy) | 45,000 | $0.00 | - | |
| Ashoo Gupta - Officer | Option exercise | Common Stock | 866 | - | - | |
| Ashoo Gupta - Officer | Open-market sale | Common Stock | 310 | $8.68 | $3K | |
| Ashoo Gupta - Officer | Option exercise | Common Stock | 220 | - | - | |
| Ashoo Gupta - Officer | Open-market sale | Common Stock | 79 | $8.68 | $686 | |
| Ashoo Gupta - Officer | Option exercise | Restricted Stock Units | 866 | $0.00 | - | |
| Ashoo Gupta - Officer | Option exercise | Restricted Stock Units | 220 | $0.00 | - | |
| Scott Bizily - Officer | Option exercise | Common Stock | 1,635 | $4.14 | $7K | |
| Scott Bizily - Officer | Open-market sale | Common Stock | 1,635 | $10.90 | $18K | |
| Scott Bizily - Officer | Option exercise | Stock Option (Right to Buy) | 1,635 | $0.00 | - | |
| Charles Theuer | Option exercise | Common Stock | 9,333 | $1.14 | $11K | |
| Charles Theuer | Option exercise | Stock Option (Right to Buy) | 9,333 | $0.00 | - | |
| Kristian Humer - Officer | Grant or award | Stock Option (Right to Buy) | 480,000 | $0.00 | - | |
| Scott Bizily - Officer | Option exercise | Common Stock | 1,635 | $4.14 | $7K | |
| Scott Bizily - Officer | Open-market sale | Common Stock | 1,635 | $10.59 | $17K | |
| Scott Bizily - Officer | Option exercise | Stock Option (Right to Buy) | 1,635 | $0.00 | - | |
| Scott Bizily - Officer | Option exercise | Common Stock | 1,084 | $6.49 | $7K | |
| Scott Bizily - Officer | Open-market sale | Common Stock | 2,678 | $12.00 | $32K | |
| Scott Bizily - Officer | Option exercise | Stock Option (Right to Buy) | 1,084 | $0.00 | - | |
| Scott Bizily - Officer | Option exercise | Common Stock | 1,635 | $4.14 | $7K | |
| Scott Bizily - Officer | Open-market sale | Common Stock | 1,635 | $10.17 | $17K | |
| Scott Bizily - Officer | Option exercise | Stock Option (Right to Buy) | 1,635 | $0.00 | - | |
| Scott Bizily - Officer | Open-market sale | Common Stock | 2,408 | $10.00 | $24K | |
| Scott Bizily - Officer | Open-market sale | Common Stock | 2,407 | $8.00 | $19K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| David Kirn | Officer | 69,076 | $1.16M | View on EDGAR | |
| SCOTT BIZILY | Officer | 6,540 | $80K | View on EDGAR | |
| SCOTT BIZILY | Officer | 1,635 | $19K | View on EDGAR |
4D Molecular Therapeutics, Inc. (FDMT) had 16 insider filings in the last 90 days, with the most recent on 2026-08-21. The full record for FDMT runs to 33 Form 4 filings, the earliest from 2024-11-13. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of FDMT were filed in the last 90 days.
13 insider sales of FDMT were filed in the last 90 days, totaling $3.69M.
This page tracks FDMT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add FDMT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
